• Intestinal TM6SF2 Deficiency Drives MASH via Gut–Liver Axis

  2026-05-22

  A recent Nature Metabolism study uncovers that intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis (MASH) by maintaining gut barrier function and microbiota balance. The research demonstrates that loss of TM6SF2 in intestinal epithelial cells leads to microbial dysbiosis, elevated lysophosphatidic acid, and hepatic inflammation, highlighting new intervention points in MASH pathogenesis.

• IEM 1460: Novel Insights into AMPA Receptor Blockade and Neu

  2026-05-21

  Explore the multifaceted role of IEM 1460 as a selective AMPA receptor blocker in neuroprotection and excitotoxicity research. This article reveals new scientific perspectives and practical guidance for neuroscience workflows, extending beyond standard protocols.

• Endothelial STING-JAK1 Axis Normalizes Tumor Vessels and Imm

  2026-05-21

  The reference study uncovers a crucial role for endothelial STING in orchestrating tumor vasculature normalization and promoting antitumor immunity via a JAK1-dependent mechanism. These findings refine our understanding of STING agonist activity and inform rational strategies for enhancing immunotherapy in cancer biology research.

• NPT1-Mediated Renal Transport of Faropenem and Organic Anion

  2026-05-20

  This study identifies human NPT1 as a key apical transporter for organic anions such as p-aminohippuric acid and clinically relevant β-lactam antibiotics like faropenem in the renal proximal tubule. These findings clarify molecular mechanisms underlying renal drug secretion and have direct implications for antibiotic pharmacokinetics and resistance studies.

• mTORC1-IRE1a Pathway Drives Palmitate Lipotoxicity in Hepato

  2026-05-20

  This study uncovers how palmitate, a saturated fatty acid, induces hepatocyte death and triglyceride overproduction via coordinated activation of the mTORC1-IRE1a axis. The findings clarify a mechanistic link between lipid overload, ER stress, and liver injury, offering new targets for metabolic disease research.

• BicD and MAP7 Synergistically Activate Drosophila Kinesin-1

  2026-05-19

  This study reveals how BicD and MAP7 activate homodimeric Drosophila kinesin-1 by distinct yet complementary mechanisms. The findings advance our understanding of adaptor-mediated control of motor proteins, with implications for dissecting intracellular transport in experimental systems.

• Harnessing CCK-8 for Precision Cell Proliferation Assays

  2026-05-19

  The Cell Counting Kit-8 (CCK-8) redefines quantitative cell viability and proliferation analysis with unmatched sensitivity and operational simplicity. This article details optimized workflows, advanced applications, and troubleshooting strategies, translating the latest research—including meniscus tissue engineering breakthroughs—into actionable guidance for experimental success.

• Cy7 NHS Ester: Technical Guidance for Near-Infrared Labeling

  2026-05-18

  Cy7 NHS ester provides a reliable solution for labeling proteins and peptides with a hydrophilic, sulfonated near-infrared dye, minimizing denaturation risk and maximizing water solubility. It is best applied in workflows requiring sensitive, in vitro or in vivo near-infrared fluorescent imaging of biomolecules with accessible amino groups, but is not suitable for long-term dye solution storage or for targets lacking reactive amines.

• Etoposide (VP-16): Applied Workflows for Cancer Research

  2026-05-18

  Etoposide (VP-16) empowers cancer biologists to dissect DNA double-strand break pathways and apoptosis with precision. This guide translates recent discoveries, including the use of LAMP1 as a senescence marker, into actionable protocols and troubleshooting tips for DNA damage assays and senolytic strategies.

• Bufuralol Hydrochloride in Human-Relevant Cardiovascular Ass

  2026-05-17

  Explore how Bufuralol hydrochloride, a non-selective β-adrenergic receptor antagonist, transforms human-relevant cardiovascular pharmacology using advanced hiPSC-derived intestinal organoids. This article uniquely bridges practical assay design and translational research, offering unprecedented insight beyond current literature.

• Gepotidacin Efficacy in Treating Drug-Resistant Gonorrhea: P

  2026-05-16

  The referenced phase 2 clinical study demonstrates that single oral doses of gepotidacin, a novel bacterial type II topoisomerase inhibitor, achieve ≥95% microbiological cure in adults with uncomplicated urogenital gonorrhea, including strains resistant to existing antibiotics. This work highlights gepotidacin’s potential as an alternative therapy amid rising multidrug resistance, with important implications for future antibiotic stewardship strategies.

• ABT-888 (Veliparib): Applied Protocols for DNA Repair Inhibi

  2026-05-15

  ABT-888 (Veliparib) is a leading PARP inhibitor for synergizing DNA damage and enhancing chemotherapy efficacy, particularly in MSI and DNA repair-deficient tumor models. This guide synthesizes advanced workflows, troubleshooting strategies, and actionable insights to maximize ABT-888’s translational value in cancer research.

• EPI-001: Streamlining Androgen Receptor N-Terminal Inhibitio

  2026-05-15

  EPI-001, a potent androgen receptor N-terminal domain inhibitor, is redefining experimental workflows in prostate and triple-negative breast cancer research. Learn how optimized protocols and troubleshooting insights can maximize AR transcriptional activity inhibition and enhance translational impact.

• Dissecting N-Type Ca Channel Blockade by v-Agatoxin-IVA in N

  2026-05-14

  Sidach and Mintz's study rigorously re-examines the pharmacological selectivity of the spider toxin v-agatoxin-IVA on neuronal calcium channels, revealing nuanced differences in toxin sensitivity among P-, Q-, and N-type channels. Their findings refine functional channel classification and highlight challenges in employing toxin-based tools for dissecting calcium channel subtypes.

• BRCA2 Shields RAD51 Filaments from PARPi-Mediated PARP1 Rete

  2026-05-14

  This study uncovers a critical mechanistic link between BRCA2 function and cellular responses to PARP inhibition. The authors demonstrate that BRCA2 prevents PARP inhibitor-induced retention of PARP1 at DNA repair sites, thereby stabilizing RAD51 filaments and supporting homologous recombination, with direct implications for DNA repair deficiency targeting strategies.

15294 records 4/1020 page Previous Next 12345 下5页 Last page